DLD Asset Management’s Array Biopharma Inc ARRY Stock Holding History

DLD Asset Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-240,000	Closed	-$11.1M	–	109
2019 Q2	$11.1M	Buy	+240,000	New	+$6.74M	0.46%	35

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

DLD Asset Management's ARRY Position: Q3 2019 in Review

DLD Asset Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 240,000 shares — an estimated $11.1M sold.

DLD Asset Management first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $11.1M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

DLD Asset Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
DLD Asset Management sold 240,000 Array Biopharma Inc shares in Q3 2019, an estimated $11.1M.
DLD Asset Management first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
DLD Asset Management's Array Biopharma Inc position peaked at $11.1M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on DLD Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.